Osteoporosis is a major concern all over the world. With aging, a gradual loss of bone mass
results in osteopenia and osteoporosis. Heritable factors account for 60–80% of optimal …

Osteoporosis is a major public health concern affecting millions of people worldwide and
resulting in significant economic costs. The condition is characterized by changes in bone …

Osteoporosis is a chronical, systemic skeletal disorder characterized by an increase in bone
resorption, which leads to reduced bone density. The reduction in bone mineral density and …

Osteoporosis is the most common chronic metabolic bone disease. It has been estimated
that more than 10 million people in the United States and 200 million men and women …

Efficient therapies are available for the treatment of osteoporosis. Anti‐resorptive therapies,
including bisphosphonates and denosumab, increase bone mineral density (BMD) and …

Osteoporosis is an unavoidable public health problem in an aging or aged society. Anti-
resorptive agents (calcitonin, estrogen, and selective estrogen-receptor modulators …

To summarize promising areas of investigation in osteoporosis and to stimulate further
research in this area, as discussed in a recent international conference. Over the recent …

Osteoporosis is one of the major bone disorders that affects both women and men, and
causes bone deterioration and bone strength. Bone remodeling maintains bone mass and …

With an increase in the ageing population worldwide, the prevalence of osteoporosis
increases at an alarming rate in both male and female irrespective of their ethnicity. At …

Recent scientific evidence has shown an increased risk of fractures in patients with obesity,
especially in those with a higher visceral adipose tissue content. This contradicts the old …